Kaoru Tanaka

6PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

|May 05, 2026
Enfortumab vedotin plus pembrolizumab as first-line treatment in recurrent or metastatic head and neck squamous cell carcinoma: results from EV-202 cohort 9.

|Nov 13, 2025
C-Reactive Protein in Immune Checkpoint Inhibitor-Associated Colitis: A Scoping Review of Evidence and Knowledge Gaps.

Ryuichi Ohta, Yoshinori Ryu, Kaoru Tanaka

|Sep 25, 2025
Peritoneal Metastasis in Non-Small Cell Lung Cancer: A Systematic Review of Clinical Features, Molecular Profiles, Diagnostic Approaches, and Outcomes.

Ryuichi Ohta, Yoshinori Ryu, Kaoru Tanaka

|Aug 28, 2025
Clinical Characteristics and Outcomes of SMARCA4-Mutated or Deficient Malignancies: A Systematic Review of Case Reports and Series.

Ryuichi Ohta, Natsumi Yamamoto, Kaoru Tanaka

|Mar 01, 2022
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial.

Naomi Kiyota, Makoto Tahara, Junki Mizusawa

Pageof 1

Frequent Collaborators

3 joint publications

Hidetoshi Hayashi

3 joint publications

Ryuichi Ohta

2 joint publications

Naomi Kiyota

2 joint publications

Makoto Tahara